TY  - JOUR

T1  - COST-EFFECTIVENESS OF USING THE UGT1A1 PHARMACOGENETIC TEST TO REDUCE THE INCIDENCE OF IRINOTECAN CHEMOTHERAPY-RELATED FEBRILE NEUTROPAENIA

JO  - VALUE IN HEALTH

PY  - 2011/11/01

AU  - Shabaruddin FH

AU  - Elliott RA

AU  - Tappenden P

AU  - Payne K

ED  - 

DO  - DOI: 10.1016/j.jval.2011.08.114

VL  - 14

IS  - 7

SP  - A251

EP  - A252

Y2  - 2024/12/21

ER  -